Moberg Pharma

6,3SEK -0,79 %
Vær den første som følger denne virksomhed

Moberg Pharma is a Swedish pharmaceutical company focused on the commercialization of proprietary medicines based on proven substances. The company mainly works in nail fungus, where Moberg Pharma is developing a new external treatment. The company has agreements with commercial partners on site in Europe and Asia, among other places. The head office is in Bromma.

Omsætning
207 t
EBIT %
-9.772,95 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
MOB
Daglig lav / høj pris
6,2 / 6,65 SEK
Markedsværdi
178,97 mio. SEK
Aktieomsætning
2,29 mio. SEK
Volumen
360 t

Finanskalender

Major Owners
Source: Millistream Market Data AB

OwnerCapitalVotes
Östersjöstiftelsen9,8 %9,8 %
Avanza Pension7,2 %7,2 %
Premium
Not activated

This content is for our Premium customers only.